Cargando…

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

Globally, human immunodeficiency virus type 1 (HIV-1) infection is a major health burden for which successful therapeutic options are still being investigated. Challenges facing current drugs that are part of the established life-long antiretroviral therapy (ART) include toxicity, development of dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Hager, Gurrola, Theodore, Berman, Rachel, Collins, Mackenzie, Sariyer, Ilker K., Nonnemacher, Michael R., Wigdahl, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811197/ https://www.ncbi.nlm.nih.gov/pubmed/35126374 http://dx.doi.org/10.3389/fimmu.2021.816515

Ejemplares similares

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy
por: Atkins, Andrew, et al.
Publicado: (2021)

Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy
por: Mohamed, Hager, et al.
Publicado: (2023)

The Expanding Therapeutic Perspective of CCR5 Blockade
por: Vangelista, Luca, et al.
Publicado: (2018)

Extracellular HIV-1 Tat Mediates Increased Glutamate in the CNS Leading to Onset of Senescence and Progression of HAND
por: Marino, Jamie, et al.
Publicado: (2020)

Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease
por: Maubert, Monique E., et al.
Publicado: (2017)

Defining Differential Genetic Signatures in CXCR4- and the CCR5-Utilizing HIV-1 Co-Linear Sequences
por: Aiamkitsumrit, Benjamas, et al.
Publicado: (2014)

Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage
por: Kilareski, Evelyn M, et al.
Publicado: (2009)

CCR5 inhibitors: Emerging promising HIV therapeutic strategy
por: Rao, Padmasri Kutikuppala Surya
Publicado: (2009)

CCR5 and HIV Infection, a View from Brussels
por: Parmentier, Marc
Publicado: (2015)

HIV-1 Tat Length: Comparative and Functional Considerations
por: Mele, Anthony R., et al.
Publicado: (2020)

Maraviroc – A CCR5 Antagonist for the Treatment of HIV-1 Infection
por: Van Der Ryst, Elna
Publicado: (2015)

Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9(+) tumors
por: Santamaria, Silvia, et al.
Publicado: (2022)

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
por: Sullivan, Neil T., et al.
Publicado: (2020)

Impact of Viral Activators and Epigenetic Regulators on HIV-1 LTRs Containing Naturally Occurring Single Nucleotide Polymorphisms
por: Shah, Sonia, et al.
Publicado: (2015)

CCAAT Enhancer Binding Protein and Nuclear Factor of Activated T Cells Regulate HIV-1 LTR via a Novel Conserved Downstream Site in Cells of the Monocyte-Macrophage Lineage
por: Dahiya, Satinder, et al.
Publicado: (2014)

Localization-Specific Expression of CCR1 and CCR5 by Mast Cell Progenitors
por: Salomonsson, Maya, et al.
Publicado: (2020)

CCR4 and CCR5 Involvement in Monocyte-Derived Macrophage Migration in Neuroinflammation
por: Kim, Jong Youl, et al.
Publicado: (2022)

Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease
por: Maubert, Monique E., et al.
Publicado: (2016)

CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab
por: Chang, Xiao L., et al.
Publicado: (2021)

Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization
por: Ferrucci, Adriano, et al.
Publicado: (2011)

Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1
por: Platt, Emily J., et al.
Publicado: (2015)

Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers
por: Picton, Anabela C. P., et al.
Publicado: (2021)

Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants
por: Dampier, Will, et al.
Publicado: (2017)

Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications
por: Zhu, Tianyi, et al.
Publicado: (2022)

Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I
por: Shah, Sonia, et al.
Publicado: (2014)

Impact of Tat Genetic Variation on HIV-1 Disease
por: Li, Luna, et al.
Publicado: (2012)

cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells
por: Banerjee, Anupam, et al.
Publicado: (2017)

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
por: Allen, Alexander G., et al.
Publicado: (2018)

The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook
por: Mohamed, Hager, et al.
Publicado: (2020)

Immune response mechanisms in acute and chronic pancreatitis: strategies for therapeutic intervention
por: Glaubitz, Juliane, et al.
Publicado: (2023)

Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas’ Heart Disease: Antagonistic Participation of CCR1(+) and CCR5(+) Cells in Chronic Chagasic Cardiomyopathy
por: Batista, Angelica Martins, et al.
Publicado: (2018)

Divergent Expression of CXCR5 and CCR5 on CD4(+) T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection
por: Zaunders, John, et al.
Publicado: (2017)

Roles of neuropathology-associated reactive astrocytes: a systematic review
por: Lawrence, Jill M., et al.
Publicado: (2023)

Editorial: CCR5: A receptor at the center stage in infection
por: Ellwanger, Joel Henrique, et al.
Publicado: (2022)

HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells
por: Xu, Yin, et al.
Publicado: (2017)

Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy
por: Chung, Cheng-Han, et al.
Publicado: (2021)

Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV
por: Matt, Stephanie M., et al.
Publicado: (2021)

Novel Therapeutic Targeting of CCL3-CCR4 Axis Mediated Apoptotic Intesitnal Injury in Necrotizing Enterocolitis
por: Yuan, Xi, et al.
Publicado: (2022)

Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy
por: Kwiatkowski, Klaudia, et al.
Publicado: (2020)

Biallelic, Selectable, Knock-in Targeting of CCR5 via CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 Replication
por: Scheller, Stefan H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2c7cl7bt8m4nive0q8of461ts1